N-(8-(3-ethynylphenoxy)octyl-1-deoxynojirimycin suppresses growth and migration of human lung cancer cells.
Zhao
Yunxue
Y
Department of Pharmacology, School of Medicine, Shandong University, Jinan, PR China. zhaoyunxue@sdu.edu.cn
Liu
Wenjia
W
Zhou
Ying
Y
Zhang
Xiumei
X
Murphy
Paul V
PV
D017485:1-Deoxynojirimycin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000627:therapeutic use; D017209:Apoptosis; D045744:Cell Line, Tumor; D002465:Cell Movement; D016193:G1 Phase; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D009844:Oligosaccharides / Q000378:metabolism; D022502:Stress Fibers / Q000378:metabolism
D000970:Antineoplastic Agents; C552356:N-(8-(3-ethynylphenoxy)octyl)-1-deoxynojirimycin; D009844:Oligosaccharides; D017485:1-Deoxynojirimycin